{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:46:57Z","timestamp":1784677617728,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["98-01-57-41979"],"award-info":[{"award-number":["98-01-57-41979"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"DOI":"10.1007\/s40199-023-00462-2","type":"journal-article","created":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T09:02:25Z","timestamp":1684573345000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fabrication, characterization and evaluation of a new designed botulinum toxin-cell penetrating peptide nanoparticulate complex"],"prefix":"10.1007","volume":"31","author":[{"given":"Nazanin Shabani","family":"Ravari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam Ghareh","family":"Sheikhlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navid","family":"Goodarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahar","family":"Kharazian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Atyabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saman A.","family":"Nasrollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0694-7556","authenticated-orcid":false,"given":"Rassoul","family":"Dinarvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,20]]},"reference":[{"issue":"3","key":"462_CR1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.cnur.2007.05.001","volume":"42","author":"PE Bermann","year":"2007","unstructured":"Bermann PE. Aging skin: causes, treatments, and prevention. Nurs Clin North Am. 2007;42(3):485\u2013500. https:\/\/doi.org\/10.1016\/j.cnur.2007.05.001.","journal-title":"Nurs Clin North Am."},{"issue":"2","key":"462_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/path.2098","volume":"211","author":"L Baumann","year":"2007","unstructured":"Baumann L. Skin ageing and its treatment. J Pathol. 2007;211(2):241\u201351. https:\/\/doi.org\/10.1002\/path.2098.","journal-title":"J Pathol."},{"issue":"8","key":"462_CR3","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/j.1365-4632.2010.04821","volume":"50","author":"D Kopera","year":"2011","unstructured":"Kopera D. Botulinum toxin historical aspects: from food poisoning to pharmaceutical. Int J Dermatol. 2011;50(8):976\u201380. https:\/\/doi.org\/10.1111\/j.1365-4632.2010.04821.","journal-title":"Int J Dermatol."},{"issue":"3","key":"462_CR4","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1080\/14764170701411470","volume":"9","author":"J Carruthers","year":"2007","unstructured":"Carruthers J, Carruthers A. The evolution of botulinum neurotoxin type a for cosmetic applications. J Cosmet Laser Ther. 2007;9(3):186\u201392. https:\/\/doi.org\/10.1080\/14764170701411470.","journal-title":"J Cosmet Laser Ther."},{"key":"462_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/cia.s9338","volume":"5","author":"K De Boulle","year":"2010","unstructured":"De Boulle K, Fagien S, Sommer B, Glogau R. Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: a review of the science, the clinical data, and patient satisfaction. Clin Interv Aging. 2010;5:101. https:\/\/doi.org\/10.2147\/cia.s9338.","journal-title":"Clin Interv Aging."},{"key":"462_CR6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.tox.2013.02.006","volume":"306","author":"A Wheeler","year":"2013","unstructured":"Wheeler A, Smith HS. Botulinum toxins: mechanisms of action, antinociception and clinical applications. Toxicology. 2013;306:124\u201346. https:\/\/doi.org\/10.1016\/j.tox.2013.02.006.","journal-title":"Toxicology."},{"issue":"2","key":"462_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.toxicon.2011.05.012","volume":"58","author":"HF Stone","year":"2011","unstructured":"Stone HF, Zhu Z, Thach TQ, Ruegg CL. Characterization of diffusion and duration of action of a new botulinum toxin type a formulation. Toxicon. 2011;58(2):159\u201367.","journal-title":"Toxicon."},{"issue":"6","key":"462_CR8","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jaad.2016.11.012","volume":"76","author":"CN Giordano","year":"2017","unstructured":"Giordano CN, Matarasso SL, Ozog DM. Injectable and topical neurotoxins in dermatology: basic science, anatomy, and therapeutic agents. J Am Acad Dermatol. 2017;76(6):1013\u201324. https:\/\/doi.org\/10.1016\/j.jaad.2016.11.012.","journal-title":"J Am Acad Dermatol."},{"issue":"16","key":"462_CR9","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s00018-005-5109-0","volume":"62","author":"S Deshayes","year":"2005","unstructured":"Deshayes S, Morris M, Divita G, Heitz F. Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Cell Mol Life Sci. 2005;62(16):1839\u201349. https:\/\/doi.org\/10.1007\/s00018-005-5109-0.","journal-title":"Cell Mol Life Sci."},{"issue":"1758","key":"462_CR10","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.bbamem.2006.02.012","volume":"3","author":"P J\u00e4rver","year":"2006","unstructured":"J\u00e4rver P, Langel \u00dc. Cell-penetrating peptides\u2014a brief introduction. Bba-Biomembranes. 2006;3(1758):260\u20133. https:\/\/doi.org\/10.1016\/j.bbamem.2006.02.012.","journal-title":"Bba-Biomembranes."},{"issue":"2","key":"462_CR11","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1096\/fj.12-216176","volume":"27","author":"C Bechara","year":"2013","unstructured":"Bechara C, Pallerla M, Zaltsman Y, Burlina F, Alves ID, Lequin O, Sagan S. Tryptophan within basic peptide sequences triggers glycosaminoglycan-dependent endocytosis. FASEB J. 2013;27(2):738\u201349. https:\/\/doi.org\/10.1096\/fj.12-216176.","journal-title":"FASEB J."},{"key":"462_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60761-919-2","volume-title":"Cell-penetrating peptides","author":"\u00dc Langel","year":"2011","unstructured":"Langel \u00dc. Cell-penetrating peptides. Springer; 2011."},{"issue":"4","key":"462_CR13","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.addr.2004.10.010","volume":"57","author":"M Zorko","year":"2005","unstructured":"Zorko M, Langel \u00dc. Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv Drug Deliv Rev. 2005;57(4):529\u201345. https:\/\/doi.org\/10.1016\/j.addr.2004.10.010.","journal-title":"Adv Drug Deliv Rev."},{"issue":"11","key":"462_CR14","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s11095-007-9303-7","volume":"24","author":"LN Patel","year":"2007","unstructured":"Patel LN, Zaro JL, Shen W-C. Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives. Pharm Res. 2007;24(11):1977\u201392. https:\/\/doi.org\/10.1007\/s11095-007-9303-7.","journal-title":"Pharm Res."},{"issue":"12","key":"462_CR15","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.febslet.2013.04.031","volume":"587","author":"C Bechara","year":"2013","unstructured":"Bechara C, Sagan S. Cell-penetrating peptides: 20 years later, where do we stand? FEBS Lett. 2013;587(12):1693\u2013702. https:\/\/doi.org\/10.1016\/j.febslet.2013.04.031.","journal-title":"FEBS Lett."},{"issue":"12","key":"462_CR16","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nbt1201-1173","volume":"19","author":"MC Morris","year":"2001","unstructured":"Morris MC, Depollier J, Mery J, Heitz F, Divita G. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol. 2001;19(12):1173\u20136. https:\/\/doi.org\/10.1038\/nbt1201-1173.","journal-title":"Nat Biotechnol."},{"issue":"1","key":"462_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2008-2231-21-58","volume":"21","author":"S Manoochehri","year":"2013","unstructured":"Manoochehri S, Darvishi B, Kamalinia G, Amini M, Fallah M, Ostad SN, Atyabi F, Dinarvand R. Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel. DARU J Pharm Sci. 2013;21(1):1\u201310. https:\/\/doi.org\/10.1186\/2008-2231-21-58.","journal-title":"DARU J Pharm Sci."},{"issue":"10","key":"462_CR18","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1002\/ijc.25578","volume":"128","author":"JY Lee","year":"2011","unstructured":"Lee JY, Choi YS, Suh JS, Kwon YM, Yang VC, Lee SJ, Chung CP, Park YJ. Cell-penetrating chitosan\/doxorubicin\/TAT conjugates for efficient cancer therapy. Int J Cancer. 2011;128(10):2470\u201380. https:\/\/doi.org\/10.1002\/ijc.25578.","journal-title":"Int J Cancer."},{"key":"462_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.toxicon.2013.05.004","volume":"71","author":"RS Broide","year":"2013","unstructured":"Broide RS, Rubino J, Nicholson GS, Ardila MC, Brown MS, Aoki KR, Francis J. The rat digit abduction score (DAS) assay: a physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysis. Toxicon. 2013;71:18\u201324. https:\/\/doi.org\/10.1016\/j.toxicon.2013.05.004.","journal-title":"Toxicon."},{"issue":"6","key":"462_CR20","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1128\/jb.79.1.18-23.1960","volume":"7","author":"P Bonventre","year":"1959","unstructured":"Bonventre P, Kempe L. Physiology of toxin production by clostridium botulinum types a and B: III. Effect of pH and temperature during incubation on growth, autolysis, and toxin production. Appl Microbiol. 1959;7(6):374\u20137. https:\/\/doi.org\/10.1128\/jb.79.1.18-23.1960.","journal-title":"Appl Microbiol."},{"issue":"2","key":"462_CR21","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1124\/pr.116.012658","volume":"69","author":"M Pirazzini","year":"2017","unstructured":"Pirazzini M, Rossetto O, Eleopra R, Montecucco C. Botulinum neurotoxins: biology, pharmacology, and toxicology. Pharmacol Rev. 2017;69(2):200\u201335. https:\/\/doi.org\/10.1124\/pr.116.012658.","journal-title":"Pharmacol Rev."},{"key":"462_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jconrel.2014.08.014","volume":"194","author":"N-Q Shi","year":"2014","unstructured":"Shi N-Q, Qi X-R, Xiang B, Zhang Y. A survey on \u201cTrojan horse\u201d peptides: opportunities, issues and controlled entry to \u201cTroy\u201d. J Control Release. 2014;194:53\u201370. https:\/\/doi.org\/10.1016\/j.jconrel.2014.08.014.","journal-title":"J Control Release."},{"key":"462_CR23","unstructured":"Drugs@FDA: FDA-Approved Drugs. [cited 2022 10-8]; Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=BasicSearch.process."},{"key":"462_CR24","unstructured":"Drug Approval Package: DAXXIFY. [cited 2022 10-08]; Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2022\/761127Orig1s000TOC.cfm."},{"issue":"5","key":"462_CR25","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1021\/bc500017t","volume":"25","author":"R Brock","year":"2014","unstructured":"Brock R. The uptake of arginine-rich cell-penetrating peptides: putting the puzzle together. Bioconjug Chem. 2014;25(5):863\u20138. https:\/\/doi.org\/10.1021\/bc500017t.","journal-title":"Bioconjug Chem."},{"issue":"25","key":"462_CR26","doi-asserted-by":"publisher","first-page":"16010","DOI":"10.1074\/jbc.272.25.16010","volume":"272","author":"E Vives","year":"1997","unstructured":"Vives E, Brodin P, Lebleu B. A truncated HIV-1 tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem. 1997;272(25):16010\u20137. https:\/\/doi.org\/10.1074\/jbc.272.25.16010.","journal-title":"J Biol Chem."},{"issue":"8","key":"462_CR27","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1128\/CVI.00268-13","volume":"20","author":"A Ben David","year":"2013","unstructured":"Ben David A, Diamant E, Barnea A, Rosen O, Torgeman A, Zichel R. The receptor binding domain of botulinum neurotoxin serotype a (BoNT\/a) inhibits BoNT\/a and BoNT\/E intoxications in vivo. Clin Vaccine Immunol. 2013;20(8):1266\u201373. https:\/\/doi.org\/10.1128\/CVI.00268-13.","journal-title":"Clin Vaccine Immunol."},{"issue":"6","key":"462_CR28","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1007\/s00253-015-7240-7","volume":"100","author":"P Saffarian","year":"2016","unstructured":"Saffarian P, Peerayeh SN, Amani J, Ebrahimi F, Sedighian H, Halabian R, Fooladi AAI. TAT-BoNT\/a (1\u2013448), a novel fusion protein as a therapeutic agent: analysis of transcutaneous delivery and enzyme activity. Appl Microbiol Biotechnol. 2016;100(6):2785\u201395. https:\/\/doi.org\/10.1007\/s00253-015-7240-7.","journal-title":"Appl Microbiol Biotechnol."},{"issue":"5","key":"462_CR29","doi-asserted-by":"publisher","first-page":"642","DOI":"10.5483\/bmbrep.2006.39.5.642","volume":"39","author":"D-W Kim","year":"2006","unstructured":"Kim D-W, Kim S-Y, An J-J, Lee S-H, Jang S-H, Won M-H, Kang T-C, Chung K-H, Jung H-H, Cho S-W. Expression, purification and transduction of PEP-1-botulinum neurotoxin type a (PEP-1-BoNT\/a) into skin. BMB Rep. 2006;39(5):642\u20137. https:\/\/doi.org\/10.5483\/bmbrep.2006.39.5.642.","journal-title":"BMB Rep."},{"issue":"2","key":"462_CR30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/cbdd.12150","volume":"82","author":"S Ahmad Nasrollahi","year":"2013","unstructured":"Ahmad Nasrollahi S, Taghibiglou C, Fouladdel S, Dinarvand R, Moosavi Movahedi AA, Azizi E, Farboud ES. Physicochemical and biological characterization of P ep-1\/elastin complexes. Chem Biol Drug Des. 2013;82(2):189\u201395. https:\/\/doi.org\/10.1111\/cbdd.12150.","journal-title":"Chem Biol Drug Des."},{"issue":"5","key":"462_CR31","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1034\/j.1399-3011.2000.00723","volume":"56","author":"DJ Mitchell","year":"2000","unstructured":"Mitchell DJ, Steinman L, Kim D, Fathman C, Rothbard J. Polyarginine enters cells more efficiently than other polycationic homopolymers. J Pept Res. 2000;56(5):318\u201325. https:\/\/doi.org\/10.1034\/j.1399-3011.2000.00723.","journal-title":"J Pept Res."},{"issue":"3695","key":"462_CR32","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1126\/science.150.3695.501","volume":"150","author":"HJ-P Ryser","year":"1965","unstructured":"Ryser HJ-P, Hancock R. Histones and basic polyamino acids stimulate the uptake of albumin by tumor cells in culture. Science. 1965;150(3695):501\u20133. https:\/\/doi.org\/10.1126\/science.150.3695.501.","journal-title":"Science."},{"key":"462_CR33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/978-1-4939-2806-4_27","volume-title":"Cell-penetrating peptides","author":"J Lee","year":"2015","unstructured":"Lee J, Kennedy P, Waugh JM. Experiences with CPP-based self assembling peptide systems for topical delivery of botulinum toxin. In: Cell-penetrating peptides. Springer; 2015. p. 397\u2013415."},{"issue":"3","key":"462_CR34","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.bbamem.2006.02.006","volume":"1758","author":"E Gros","year":"2006","unstructured":"Gros E, Deshayes S, Morris MC, Aldrian-Herrada G, Depollier J, Heitz F, Divita G. A non-covalent peptide-based strategy for protein and peptide nucleic acid transduction. Bba-Biomembranes. 2006;1758(3):384\u201393. https:\/\/doi.org\/10.1016\/j.bbamem.2006.02.006.","journal-title":"Bba-Biomembranes."},{"key":"462_CR35","doi-asserted-by":"publisher","unstructured":"Waugh JM, Lee J, Dake MD, Browne D. Nonclinical and clinical experiences with CPP-based self-assembling peptide systems in topical drug development. Cell-penetrating. Peptides. 2011:553\u201372. https:\/\/doi.org\/10.1007\/978-1-60761-919-2_39.","DOI":"10.1007\/978-1-60761-919-2_39"},{"issue":"1","key":"462_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40199-016-0160","volume":"24","author":"N Shabani Ravari","year":"2016","unstructured":"Shabani Ravari N, Goodarzi N, Alvandifar F, Amini M, Souri E, Khoshayand MR, Hadavand Mirzaie Z, Atyabi F, Dinarvand R. Fabrication and biological evaluation of chitosan coated hyaluronic acid-docetaxel conjugate nanoparticles in CD44+ cancer cells. DARU Pharm Sci. 2016;24(1):1\u201312. https:\/\/doi.org\/10.1186\/s40199-016-0160.","journal-title":"DARU Pharm Sci."}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-023-00462-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-023-00462-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-023-00462-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T14:23:57Z","timestamp":1685715837000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-023-00462-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,20]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["462"],"URL":"https:\/\/doi.org\/10.1007\/s40199-023-00462-2","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,20]]},"assertion":[{"value":"11 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal operations were carried out in accordance with the protocol for the ethical care and use of research animals that has been authorized by Tehran University of Medical Sciences ethical committee (IR.TUMS.TIPS.REC.1397.072).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}